Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics' Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
PARAMUS, N.J., May 1, 2012 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), announces the addition of Dr. David L. Blecker MD, MPH, F.A.C.P. to the Advisory Board. Dr. Blecker, a graduate of Tufts University School of Medicine, has been practicing medicine for over 39 years and is currently the Chief in Nephrology at AtlantiCare Regional Medical Center. Dr. Blecker is also the Founder of Regional Nephrology Associates, a private practice located in south New Jersey. In addition, Dr. Blecker is an owner and operator of five Dialysis units as well as partner in Regional Nephrology Associates. He has performed clinical trials for various pharmaceutical companies including Amgen Inc., Pfizer and Merck.
"As an expert in preventive medicine and an advocate for clinical trials, I believe that the proprietary technology of Surgex allows athletes, as well as our soldiers, to function at a high performance level without the loss of muscle mass." Dr. Blecker further stated, "A technology that limits muscle waste can be utilized within the medical sector with a focus on degenerative diseases such as cancer and kidney disease."
Dr. Blecker stated, "As an advisory board member of Inergetics, I plan on developing a product and marketing strategy to reduce protein deficiency that exists within dialysis patients."
CEO Mark Mirken commented, "Dr. Blecker's access and experience with dialysis patients is extensive and will allow him to conduct clinical trials within his numerous dialysis units. This product is based on our existing long term care and immune compromised technology and will be accretive to our product portfolio targeting nutritional supplements for the medical marketplace."
About Inergetics, Inc.
Inergetics, Inc. is a leading developer of nutritional supplements for the Clinical Health and Sports Supplement markets. Inergetics has developed the Surgex® sports nutrition formula to meet the nutritional needs of professional, Olympic and amateur elite athletes that experience post-workout symptoms such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. Additionally, Inergetics has established a line of Resurgex™ products that provide comprehensive nutritional support for actively treated cancer patients as well as those in post-treatment care and elderly members of the assisted living community. To learn more about Inergetics, visit www.inergetics.com, the Resurgex™ product website and online store, and www.resurgex.com, and the Surgex® product website and online store at www.surgexsports.com.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of Inergetics set forth herein and those preceded by or that include the words "believes," "expects," "given," "targets," "intends," "anticipates," "plans," "projects," "forecasts," or similar expressions, are "forward-looking statements." Although Inergetics' management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause Inergetics' future results to differ materially from those anticipated. Inergetics assumes no obligation to update any of the information contained or referenced in this press release.
SOURCE Inergetics, Inc.